These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 5003589)

  • 1. [Experiences in the treatment of chronic myeloid leukemia].
    Pensabene A; Panzacchi G; Cipriani D
    Haematologica; 1971; 56(3):163-8. PubMed ID: 5003589
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical trial of hydroxyurea in chronic myelocytic leukemia.
    Baudo F; Cattaneo N; Cipriani D; De Cataldo F; Pensabene A; Tiso R
    Haematol Lat; 1967; 10(4):359-62. PubMed ID: 5243231
    [No Abstract]   [Full Text] [Related]  

  • 3. Chemotherapy with hydroxyurea, leucopheresis and splenectomy in the treatment of chronic myeloid leukemia at the problastic phase.
    Schwarzenberg L; Mathe G; Pouillart P; Weiner R; Lacour J; Genin J; Schneider M; de Vassal F; Hayat M; Amiel JL; Schlumberger JR; Jasmin C; Rosenfeld C
    Haematologica; 1972 Apr; 57(11):601-11. PubMed ID: 4200296
    [No Abstract]   [Full Text] [Related]  

  • 4. Hydroxyurea (Biosupressin-BIOGAL) for the treatment of chronic myelogenous leukaemia.
    Klener P; Donner L
    Ther Hung; 1981; 29(1):38-41. PubMed ID: 6964902
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment of chronic myeloid leukemia with hydroxyurea].
    Djaldetti M
    Harefuah; 1971 Nov; 81(9):438-41. PubMed ID: 5291276
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of hydroxyurea treatment on free nucleotides in leukemic leukocytes].
    Maj S; Zdebska E
    Acta Haematol Pol; 1975; 6(3):211-6. PubMed ID: 1057841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Preliminary studies on the effectiveness of the association cytosine-arabinoside, thioguanine, hydroxyureas in the treatment of blastic crisis in chronic myeloid leukemia].
    Papa G; Amadori S; Monarca B; Alimena G; Esposito A; Mandelli F
    Haematologica; 1972; 58(9):597-600. PubMed ID: 4206235
    [No Abstract]   [Full Text] [Related]  

  • 8. [Hydroxyurea in the treatment of chronic myeloid leukemia].
    Pensabene A; Cipriani D
    Haematol Lat; 1969; 12(3):767-70. PubMed ID: 5273184
    [No Abstract]   [Full Text] [Related]  

  • 9. [The use of hydroxyurea (Biosuppressin) in the accelerated phase of chronic myeloid leukemia].
    Kiss A; Jakó J; Rák K
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1981; 108(2):275-80. PubMed ID: 6168539
    [No Abstract]   [Full Text] [Related]  

  • 10. [Survival in chronic myeloid leukemia following aplasia caused by Misulban].
    Perreau P; Gardais J
    Sem Hop; 1969 Mar; 45(15):964-70. PubMed ID: 4307171
    [No Abstract]   [Full Text] [Related]  

  • 11. Hydroxyurea its value in 50 cases of advanced cancers.
    Patel D
    Indian J Cancer; 1973 Dec; 10(4):423-7. PubMed ID: 4525643
    [No Abstract]   [Full Text] [Related]  

  • 12. [Prognostic factors in chronic myeloid leukemia. Apropos of 798 cases].
    Jacquillat C; Chastang C; Bancalari G; Weil M; Bernard J
    Ann Med Interne (Paris); 1975; 126(6-7):515-20. PubMed ID: 1065252
    [No Abstract]   [Full Text] [Related]  

  • 13. Hydroxyurea as a cause of drug fever in chronic myeloid leukaemia.
    Blonk MC; Ossenkoppele GJ
    Neth J Med; 1988 Jun; 32(5-6):240-2. PubMed ID: 3164836
    [No Abstract]   [Full Text] [Related]  

  • 14. [Trial treatment of chronic myeloid leukemia with 3 new chemotherapeutic agents: dibromomannitol, hydroxyurea and desacetamidocolchicine].
    Cattan A; Schneider M; Schwarzenberg L; Amiel JJ; Schlumberger JR; Gluckman E; Mathé G
    Sem Hop; 1966 Nov; 42(49):2966-9. PubMed ID: 4292624
    [No Abstract]   [Full Text] [Related]  

  • 15. Hydroxyurea therapy in chronic myeloid leukemia.
    Agarwal MB; Mehta BC
    J Assoc Physicians India; 1982 Jul; 30(7):427-8. PubMed ID: 6963266
    [No Abstract]   [Full Text] [Related]  

  • 16. [Chronic myeloid leukaemia. Clinical study and analysis of therapeutical results in 55 cases].
    Lamas S; Sanjuán I; Zabala P; Millán I; Cabrera R; Barbolla L; Menéndez J; Fernández MN
    Sangre (Barc); 1982; 27(4A):493-507. PubMed ID: 6961564
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effects of hydroxyurea in chronic myeloid leukemia. Preliminary study].
    Tanzer J; Jacquillat C; Weil M; Levy D; Najean Y; Boiron M; Bernard J
    Presse Med (1893); 1966 Dec; 74(56):2929-30. PubMed ID: 5225193
    [No Abstract]   [Full Text] [Related]  

  • 18. [Experience in acceleration and blastic crisis in chronic myelocytic leukemia].
    Pralle H; Löffler H
    Verh Dtsch Ges Inn Med; 1978; (84):204-6. PubMed ID: 283639
    [No Abstract]   [Full Text] [Related]  

  • 19. [Cutaneous lesions induced by long-term use of hydroxyurea].
    Sigal M; Crickx B; Blanchet P; Perron J; Simony J; Belaïch S
    Ann Dermatol Venereol; 1984; 111(10):895-900. PubMed ID: 6240956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The treatment of chronic leukaemia.
    Shaw S
    Practitioner; 1970 Jun; 204(224):773-9. PubMed ID: 5271298
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.